Product Program year 2025 Source: CMS Open Payments

Alcon Greishaber Finesse

Device Ophthalmology

PDI 07612717071421

Open in the dashboard

General payments

$256,098

100 payments

Research payments

$0

0 payments

Through program year 2025, $256,098 in general payments and $0 in research payments were reported against Alcon Greishaber Finesse (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $13,561 31
2024 General $7,000 1
2023 General $6,982 5
2022 General $228,556 63

Breakdown

Who paid General payments · program years 2022–2025
  1. Alcon Vision LLC $212,698 92 payments
  2. Alcon Research LLC $43,400 8 payments
Top recipients General payments · program year 2025
  1. Arthur Brant Ophthalmology · Boston, MA $944 7% · 1 payment
  2. Marta Stevanovic Ophthalmology · Boston, MA $856 6% · 1 payment
  3. Michael Maywood Retina Specialist · Edina, MN $782 6% · 1 payment
  4. Yicheng Bao Ophthalmology · Los Angeles, CA $627 5% · 1 payment
  5. Omesh Gupta Ophthalmology · Plymouth Meeting, PA $553 4% · 1 payment

The top 5 of 31 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $9,983 79% · 22 practitioners
  2. Retina Specialist Ophthalmology $2,617 21% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $3,888 29% · 8 recipients
  2. Illinois $1,845 14% · 5 recipients
  3. New York $1,819 13% · 5 recipients
  4. Texas $1,487 11% · 4 recipients
  5. Massachusetts $1,158 9% · 2 recipients

The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

100 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record